title: Riboflavin-Ultraviolet A Corneal Cross-linking for Keratoconus.
abstract: OBJECTIVE
  To evaluate the safety, efficacy of riboflavin-ultraviolet A irradiation (UVA) corneal cross-linking and present refractive changes induced by the treatment in cases of keratoconus.
  
  
  METHODS
  The study includes 15 eyes of 9 patients with keratoconus with an average keratometric (K) reading less than 54 D and minimal corneal thickness greater than 420 microns. The corneal epithelium was removed manually within the central 8.5 mm diameter area and the cornea was soaked with riboflavin eye drops (0.1% in 20% dextran tau-500) for 30 minutes followed by exposure to UVA radiation (365 nm, 3 mW/cm(2)) for 30 minutes. During the follow-up period, uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), manifest refraction, slit lamp examination and topographic changes were recorded at the first week, first month, 3 and 6 months.
  
  
  RESULTS
  There was statistically significant improvement of UCVA from a preoperative mean of 0.11 +/- 0.07 (range 0.05-0.3) to a postoperative mean of 0.15 +/- 0.06 (range 0.1-0.3) (P < 0.05). None of the eyes lost lines of preoperative UCVA but 1 eye lost 1 line of preoperative BSCVA. The preoperative mean K of 49.97 +/- 2.81 D (range 47.20-51.75) changed to 48.34 +/- 2.64 D (range 45.75-50.40). This decrease in K readings was statistically significant (P < 0.05). All eyes developed minimal faint stromal haze that cleared in 14 eyes within 1 month. In only 1 eye, this resulted in a very faint corneal scar. Other sight threatening complications were not encountered in this series. Progression of the original disease was not seen in any of the treated eyes within 6 months of follow-up.
  
  
  CONCLUSIONS
  Riboflavin-UVA corneal cross-linking is a safe and promising method for keratoconus. Larger studies with longer follow up are recommended.
authors.affiliation: Department of Ophthalmology - Ain Shams University - Cairo, Egypt.
authors.forename: Tamer M
authors.initials: TM
authors.lastname: El-Raggal
references.citation: Invest Ophthalmol Vis Sci. 1998 Feb;39(2):220-6
references.pmid: 9477978
references.citation: Cornea. 1997 May;16(3):345-51
references.pmid: 9143810
references.citation: Am J Ophthalmol. 2003 May;135(5):620-7
references.pmid: 12719068
references.citation: J Cataract Refract Surg. 2003 Sep;29(9):1780-5
references.pmid: 14522301
references.citation: Cornea. 2002 Mar;21(2):206-9
references.pmid: 11862097
references.citation: Curr Eye Res. 1997 Aug;16(8):792-801
references.pmid: 9255508
references.citation: J Cataract Refract Surg. 2006 May;32(5):837-45
references.pmid: 16765803
references.citation: Cornea. 1992 Nov;11(6):553-9
references.pmid: 1468218
references.citation: J Cataract Refract Surg. 2003 Sep;29(9):1786-90
references.pmid: 14522302
references.citation: Surv Ophthalmol. 1998 Jan-Feb;42(4):297-319
references.pmid: 9493273
references.citation: Ophthalmic Res. 1998;30(5):327-32
references.pmid: 9704337
references.citation: Invest Ophthalmol Vis Sci. 1998 Mar;39(3):644-8
references.pmid: 9501878
references.citation: J Refract Surg. 1999 Nov-Dec;15(6):711-3
references.pmid: 10590015
references.citation: Curr Opin Ophthalmol. 2006 Aug;17(4):356-60
references.pmid: 16900027
references.citation: Curr Eye Res. 2001 May;22(5):333-40
references.pmid: 11600933